GC
NPSP

Globeflex Capital’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Globeflex Capital’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-26,400
Closed -$686K – 639
2014
Q3 		$686K Buy
+26,400
New +$758K 0.08% 273

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Globeflex Capital's NPSP Position: Q4 2014 in Review

Globeflex Capital sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2014, closing a stake of 26,400 shares — an estimated $686K sold.

Globeflex Capital first reported a position in NPSP in Q3 2014 and held it in 1 quarter. The position peaked at $686K in Q3 2014. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

  • Globeflex Capital reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Globeflex Capital sold 26,400 NPS PHARMACEUTICALS INC shares in Q4 2014, an estimated $686K.
  • Globeflex Capital first reported a position in NPS PHARMACEUTICALS INC in Q3 2014 and held it in 1 quarter.
  • Globeflex Capital's NPS PHARMACEUTICALS INC position peaked at $686K in Q3 2014.
  • 213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on Globeflex Capital's 13F filing for Q4 2014, filed 10 Feb 2015.